Hepatitis B vaccine study for healthy people aged 10-50
Part of Digestive system, Infections clinical trials.
This study tests a new hepatitis B vaccine to see if it is safe and helps the body fight the virus. It is for healthy people who have not had a hepatitis B vaccine in the last 10 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 50 years old.
- You are generally healthy, with no serious current or past illnesses.
- You have not had a hepatitis B vaccine in the last 10 years.
- You have no known allergies to vaccine components.
- You are not pregnant or breastfeeding (if applicable).
- You have not received any other vaccines in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a hepatitis B vaccine (with an added ingredient to boost the immune response) can safely help people with long-term hepatitis B who are already on antiviral therapy. It is mainly looking at safety and how the immune system responds.
This trial tests a new way of giving the hepatitis B vaccine using a patch with tiny needles that goes on the skin. For healthy adults who have not been vaccinated against hepatitis B since childhood, this could be a more comfortable and easier way to protect against the infection.
This study looks at how your body's cells respond after getting a hepatitis B vaccine. It may help researchers understand how well the vaccine works.
This trial tests an experimental vaccine to help your immune system fight chronic hepatitis B, with the goal of controlling or possibly curing the infection. It's a early-stage study, so the main goals are safety and finding the right dose.
This trial tests a new vaccine to treat chronic hepatitis B. It's for people who have been on antiviral medication for at least 6 months and still have a low level of the virus in their blood.
This study tests whether two different hepatitis B vaccines can be used interchangeably for the first dose given at birth. It aims to ensure both vaccines protect newborns equally well.
Hear when a new Vaccine Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.